<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00904956</url>
  </required_header>
  <id_info>
    <org_study_id>GRANLATHU</org_study_id>
    <nct_id>NCT00904956</nct_id>
  </id_info>
  <brief_title>Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner</brief_title>
  <acronym>GRANLATHU</acronym>
  <official_title>Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CIBERES CRP-TB program</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Germans Trias i Pujol Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is traditionally considered that someone with a positive tuberculin skin test (TST)
      (and/or positive result in Cell Interferon-Gamma Release Assay (TIGRA), depending on the
      different countries' guidelines) is infected but not ill when the absence of lesions is
      demonstrated in a thorax X-Ray assay. Even though, the experiences described in literature
      using cows and pigs as animal models for the study of LTBI demonstrate the presence of this
      kind of lesion in the animals, even too small to be detected by X-Ray assay, which would
      suggest they also could happen in human LTBI. Nowadays, the High Resolution Scanners (HR TC)
      offer the possibility of detecting any lesion approximately 1 mm in diameter, so the
      investigators plan to use this technique to screen people already infected by M. tuberculosis
      (but not ill, following the Diagnosis Standard Guidelines).

      Additional pathological analysis of resected and post-mortem tissues will provide
      lesion-based profiles of humans infected with tuberculosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is traditionally considered that the development of LTBI is due to the M. tuberculosis
      ability to develop a dormancy state within well-structured lesions (granulomas), which can
      remain in the lung of the host even for life. The investigators have developed a new original
      hypothesis based on scientific evidence that takes into account the idea that a lesion cannot
      be held forever, because the host tends to remove any lesion in order to rebuild the original
      parenchyma, in a healing process. Even if M. tuberculosis can remain in a
      dormant/non-replicating state for a long period, this is an important but not sufficient
      factor to explain the LTBI. The Dynamic Hypothesis tries to explain the existence of LTBI in
      spite of the healing process that could remove it by a constant reinfection of the host's
      tissue.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Tuberculosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Only a single population is going to be studied: the LTBI, thus people with proof to be M.
        tuberculosis infected but demonstrating not having active disease.

        As the first approach to demonstrate the Dynamic Hypothesis in humans, up to 6 people will
        be included as controls.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  People with TST+ (plus positive TIGRA result, if possible) and normal thorax X-ray
             assay (normal as absence of any detectable lesion)

        Exclusion Criteria:

          -  Active TB

          -  Any medical condition or illness that could compromise the volunteer's health if
             entering the project
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pere-Joan Cardona, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Fundació Institut Germans Trias i Pujol</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina Vilaplana, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut Germans Trias i Pujol</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cristina Vilaplana, MD</last_name>
    <phone>+349344978681</phone>
    <email>cvilaplana@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pere-Joan Cardona, MD, PhD</last_name>
    <phone>+349344978686</phone>
    <email>pjcardona.igtp.germanstrias@gencat.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fundació Institut Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Cristina Vilaplana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Juan Ruiz-Manzano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irma Casas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Esteve, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gustavo Tapia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Teknon Foundation</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Manuel Escobar, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nadine Romera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Cardona PJ. A dynamic reinfection hypothesis of latent tuberculosis infection. Infection. 2009 Apr;37(2):80-6. doi: 10.1007/s15010-008-8087-y. Epub 2009 Mar 23. Review.</citation>
    <PMID>19308318</PMID>
  </reference>
  <reference>
    <citation>Cáceres N, Tapia G, Ojanguren I, Altare F, Gil O, Pinto S, Vilaplana C, Cardona PJ. Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models. Tuberculosis (Edinb). 2009 Mar;89(2):175-82. doi: 10.1016/j.tube.2008.11.001. Epub 2008 Dec 24.</citation>
    <PMID>19110471</PMID>
  </reference>
  <reference>
    <citation>Cardona PJ. New insights on the nature of latent tuberculosis infection and its treatment. Inflamm Allergy Drug Targets. 2007 Mar;6(1):27-39. Review.</citation>
    <PMID>17352686</PMID>
  </reference>
  <reference>
    <citation>Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009 May;33(5):956-73. doi: 10.1183/09031936.00120908.</citation>
    <PMID>19407047</PMID>
  </reference>
  <reference>
    <citation>Gil O, Díaz I, Vilaplana C, Tapia G, Díaz J, Fort M, Cáceres N, Pinto S, Caylà J, Corner L, Domingo M, Cardona PJ. Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs. PLoS One. 2010 Apr 6;5(4):e10030. doi: 10.1371/journal.pone.0010030.</citation>
    <PMID>20386605</PMID>
  </reference>
  <reference>
    <citation>Cardona PJ. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch Immunol Ther Exp (Warsz). 2010 Feb;58(1):7-14. doi: 10.1007/s00005-009-0062-5. Epub 2010 Jan 5. Review.</citation>
    <PMID>20049645</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2009</study_first_submitted>
  <study_first_submitted_qc>May 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2009</study_first_posted>
  <last_update_submitted>July 8, 2011</last_update_submitted>
  <last_update_submitted_qc>July 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Pere-Joan Cardona</name_title>
    <organization>Fundació Institut Germans Trias i Pujol</organization>
  </responsible_party>
  <keyword>Latent Tuberculosis Infection</keyword>
  <keyword>High Resolution Scanners</keyword>
  <keyword>Dynamic Hypothesis of Latent Tuberculosis Infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Latent Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

